In this prospective cohort study, duration-based criteria reduced racial disparities in lung cancer screening eligibility, increasing access for minority groups compared with current US guidelines. 2.
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...